April 8, 2008 - A study using Itamar Medical's Endo-PAT2000, an FDA-cleared device used to assess endothelial function, found that when indoor air particles are reduced in a controlled study environment, endothelial function, an indicator of cardiovascular health, significantly improves.

April 8, 2008 - The first-in-man study funded by MIV Therapeutics Inc. (MIV) showed that MIV's VESTAsync stents performed as well or better than commercially available drug stent combinations, while using 60 percent less drug, according to data presented at the American College of Cardiology conference in Chicago, IL.

April 8, 2008 - Doctors at Boston Medical Center (BMC) led by Chief of Cardiac Surgery Robert Poston, M.D., have been performing minimally invasive, robotically-assisted bypass surgery, in a procedure that allows physicians to gain access to the heart with several small incisions, unlike conventional bypass surgery, which requires the chest to be opened with a 6- to 10-inch incision at the breastbone (sternum.)

April 8, 2008 - OrbusNeich received CE Mark approval for the Sapphire 1.25-mm PTCA dilatation catheter, a small-diameter balloon catheter designed specifically for the pre-dilatation of tight, calcified chronic total occlusion (CTO) lesions that require the best crossability, providing physicians with enhanced pushability and superior kink resistance.

April 8, 2008 - Atrial fibrillation demonstrated that a port access, paracardioscopic Ex-Maze procedure produced favorable outcomes and allowed patients to discontinue antiarrhythmic drugs, according to interim results from a study presented by Andy C. Kiser, M.D., at the American College of Cardiology meeting in Chicago, IL.

April 8, 2008 - Philips launched the latest addition to its HD ultrasound family of products, the Philips HD7, in the U.S. designed for high-volume use in cardiovascular, OB/GYN, anesthesiology, oncology, electrophysiology, stress echo, pediatric, orthopedic, urologic, emergency and other applications.

April 8, 2008 - Battelle, a nonprofit independent research and development organization, and MEDRAD Inc. won a Medical Design Excellence Award (MDEA) for the MEDRAD XDS Extravasation Detector, a device for the enhancement of the safety of contrast media injection through early detection of extravasations.

Battelle worked closely with MEDRAD to develop the technology from exploration through product development. MEDRAD and Battelle jointly invented the electrical permittivity technology that enables XDS and developed the commercial product.

Itamar Medical's Endo-PAT2000 is an FDA-cleared device used to assess endothelial function.

MEDRAD Inc. won a Medical Design Excellence Award (MDEA) for the MEDRAD XDS Extravasation Detector, a device for the enhancement of the safety of contrast media injection through early detection of extravasations.

The XDS continuously monitors the tissue immediately surrounding and directly beneath the injection site for changes in relative permittivity signaling fluid accumulation.

The Philips HD7 is a high-volume ultrasound system used in cardiovascular, OB/GYN, anesthesiology, oncology, electrophysiology, stress echo, pediatric, orthopedic, urologic, emergency and other applications.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now